The drop in coverage for routine vaccinations against diseases like measles, mumps and rubella (MMR) increase the chances of an outbreak and underscore the continued fallout from barriers to vaccination during the COVID-19 pandemic.
New data from the Centers for Disease Control and Prevention (CDC) show cases are at the highest level in at least 30 years. There were more than 3,700 infants born with syphilis in 2022, a tenfold increase over the past 10 years.
The chief scientist from the World Health Organization is warning that Earth’s rising temperature will make dengue fever a massive threat within this decade.
“Widespread access [to the new antibody drug] will take time across many sectors of the pediatric population and won’t have as great an impact on volumes this immediate respiratory season,” the Children’s Hospital Association said in a statement.
New research has identified 38 direct-to-consumer businesses marketing stem-cell treatments and exosome therapies for COVID-19 infections and, especially, long COVID, despite lacking approval by US Food and Drug Administration and other regulatory body in the United States. Descriptions of the businesses and an analysis of their marketing strategies are published in Stem Cell Reports.
